SANUWAVE HEALTH INC (SNWV) Stock Earnings & Estimates
USA - NASDAQ:SNWV - US80303D3052 - Common Stock
32.97 USD
+0.31 (+0.95%)
32.94 USD
-0.03 (-0.09%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.742M 28.69% | 20.398M 21.84% | 32.634M 59.99% | 45.327M 38.90% | 59.919M 32.19% | 80.855M 34.94% | |
| EBITDA YoY % growth | -8M 38.01% | 488K 106.10% | 6.562M 1,244.67% | 15.523M 136.56% | 21.442M 38.13% | 22.604M 5.42% | |
| EBIT YoY % growth | -8.952M 36.70% | -540K 93.97% | 5.417M 1,103.15% | 9.353M 72.66% | 14.378M 53.73% | 22.604M 57.21% | |
| Operating Margin | -53.47% | -2.65% | 16.60% | 20.63% | 24.00% | 27.96% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.06 | 1.10 2,062.73% | 2.24 103.80% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.32 | 0.20 116.82% | 0.17 | 0.14 1,307.60% | 0.27 -18.24% | 0.37 80.45% | 0.29 68.45% | 0.35 145.65% | 0.51 92.69% | 0.61 66.94% |
| Revenue Q2Q % growth | 11.659M 22.34% | 13.773M 33.33% | 11.526M 23.38% | 14.001M 37.75% | 17.748M 54.99% | 21.42M 55.52% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 3.876M 44.14% | 5.1M 39.08% | 3.468M 175.24% | 4.643M 89.51% | 5.406M 39.47% | 6.324M 24.00% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 2.437M 24.78% | 3.035M 20.34% | 1.966M 99.39% | 3.093M 64.78% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.01 | -0.09 | 0.10 | 111.27% |
| Q4 2020 Q2Q % growth | -15.00 -300.00% | -3.83 | -11.18 | -292.16% |
| Q3 2020 Q2Q % growth | -7.50 -100.00% | -3.83 | -3.68 | -96.08% |
| Q4 2019 Q2Q % growth | -3.75 | -3.83 | 0.08 | 1.96% |
| Q3 2019 Q2Q % growth | -3.75 | -7.65 | 3.90 | 50.98% |
| Q2 2019 Q2Q % growth | -7.50 | -7.65 | 0.15 | 1.96% |
| Q1 2019 Q2Q % growth | -3.75 | -3.83 | 0.08 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 11.451M 22.34% | 11.659M | -208K | -1.78% |
| Q2 2025 Q2Q % growth | 10.164M 41.92% | % | ||
| Q1 2025 Q2Q % growth | 9.342M 61.46% | % | ||
| Q4 2024 Q2Q % growth | 10.33M 47.70% | % | ||
| Q3 2024 Q2Q % growth | 9.36M 88.98% | % | ||
| Q2 2024 Q2Q % growth | 7.162M 53.20% | % | ||
| Q1 2024 Q2Q % growth | 5.786M 53.27% | % | ||
| Q4 2023 Q2Q % growth | 6.994M 27.16% | % | ||
| Q3 2023 Q2Q % growth | 4.953M 18.89% | % | ||
| Q2 2023 Q2Q % growth | 4.675M 20.43% | % | ||
| Q1 2023 Q2Q % growth | 3.775M 18.15% | % | ||
| Q4 2022 Q2Q % growth | 5.5M 29.11% | % | ||
| Q3 2022 Q2Q % growth | 4.166M 11.84% | % | ||
| Q2 2022 Q2Q % growth | 3.882M 33.45% | % | ||
| Q1 2022 Q2Q % growth | 3.195M 50.99% | % | ||
| Q4 2021 Q2Q % growth | 4.26M 129.16% | % | ||
| Q3 2021 Q2Q % growth | 3.725M 172.69% | % | ||
| Q2 2021 Q2Q % growth | 2.909M 3,404.82% | % | ||
| Q1 2021 Q2Q % growth | 2.116M 1,320.13% | % | ||
| Q4 2020 Q2Q % growth | 1.859M 453.27% | 3.06M | -1.201M | -39.25% |
| Q3 2020 Q2Q % growth | 1.366M 589.90% | 1.122M | 244K | 21.75% |
| Q2 2020 Q2Q % growth | 83K -73.82% | % | ||
| Q1 2020 Q2Q % growth | 149K -16.29% | % | ||
| Q4 2019 Q2Q % growth | 336K | 905.76K | -569.76K | -62.90% |
| Q3 2019 Q2Q % growth | 198K | 403.92K | -205.92K | -50.98% |
| Q2 2019 Q2Q % growth | 317K | 469.2K | -152.2K | -32.44% |
| Q1 2019 Q2Q % growth | 178K | 505.716K | -327.716K | -64.80% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 181.42% | -1200% | N/A |
| Revenue | 0% | N/A | -6.01% | N/A |